Coordinated Repair and Regeneration of Defective Mitochondria

有缺陷的线粒体的协调修复和再生

基本信息

  • 批准号:
    10560647
  • 负责人:
  • 金额:
    $ 44.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-02-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

Project Summary Mitochondrial function declines during aging and is accelerated in age-associated diseases such as Parkinson's and Alzheimer's. Thus, understanding how cells and organisms generate the appropriate mitochondrial mass during development and maintain that mitochondrial network during aging is an essential step to limiting pathologies associated with loss of mitochondrial function. Here, we aim to understand the underlying mechanisms by which the transcription factor ATFS-1 and the mitochondrial unfolded protein response (UPRmt) coordinate mitochondrial network biogenesis during normal development and the recovery of the mitochondrial network via independently regulated functions of ATFS-1 in mitochondrial compartments and the nucleus. Numerous components have been identified that promote replication of the mitochondrial genome and transcription of nuclear-encoded genes that result in mitochondrial biogenesis. However, it remains unclear how the appropriate amount of mitochondrial mass is achieved during development or cell specification, and how the mitochondrial network is maintained over a cell or organisms lifetime. It also remains unknown if mitochondrial genome (mtDNA) replication is coordinated with cell growth, physiology, or functional heterogeneity within the compartments that comprise the mitochondrial network. Current dogma suggests that mtDNA replication is entirely dependent on expression of several nuclear-encoded factors such as the mtDNA polymerase. Despite functional heterogeneity within the mitochondrial network, compartment-specific autonomy over mtDNA regulation is rarely considered. In this proposal, we aim to understand how ATFS-1 establishes the appropriate amount mitochondrial mass during development, and maintains the mitochondrial network over an animals lifetime focusing on the separate activities of nuclear ATFS-1, and the fraction of ATFS-1 that accumulates in dysfunctional mitochondria and binds mtDNA. Lastly, we aim to understand the impact of an ATFS-1-mediated diapause that occurs if the mitochondrial network is severely damaged during development. At the end of the funding period, we hope to understand the endogenous strategies in place to establish and maintain the mitochondrial network, to potentially develop strategies to promote or maintain a robust mitochondrial network.
项目摘要 线粒体功能在衰老过程中下降,并在与年龄相关的疾病中加速, 帕金森症和老年痴呆症。因此,了解细胞和生物体如何产生适当的 线粒体质量在发展和维持线粒体网络在老化是必不可少的 限制与线粒体功能丧失相关的病理的步骤。在这里,我们的目标是了解 转录因子ATFS-1和线粒体未折叠蛋白 在正常发育和恢复过程中,UPRmt反应(UPRmt)协调线粒体网络生物合成 通过ATFS-1在线粒体区室中的独立调节功能, 和原子核。 已经鉴定了许多促进线粒体基因组复制的组分, 核编码基因的转录导致线粒体生物发生。但尚不清楚 在发育或细胞特化过程中如何获得适量的线粒体质量,以及 线粒体网络如何在细胞或生物体的一生中维持。同样未知的是, 线粒体基因组(mtDNA)复制与细胞生长、生理或功能相协调 在构成线粒体网络的隔室内的异质性。目前的教条认为, mtDNA复制完全依赖于几种核编码因子的表达,如mtDNA 聚合酶。尽管线粒体网络内的功能异质性,但隔室特异性 线粒体DNA调控的自主性很少被考虑。 在这项提案中,我们的目标是了解ATFS-1如何建立适当数量的线粒体 质量在发展过程中,并维持线粒体网络在动物的一生,重点是 核ATFS-1的单独活性,以及在功能失调中积累的ATFS-1部分 线粒体并结合mtDNA。最后,我们的目标是了解ATFS-1介导的滞育的影响, 如果线粒体网络在发育过程中受到严重破坏,就会发生这种情况。在供资期结束时, 我们希望了解建立和维持线粒体的内源性策略, 网络,以潜在地开发策略,以促进或维持一个强大的线粒体网络。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cole M Haynes其他文献

Cole M Haynes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cole M Haynes', 18)}}的其他基金

Coordinating mitochondrial network expansion and longevity via the Integrated Stress Response (ISR)
通过综合应激反应 (ISR) 协调线粒体网络扩张和寿命
  • 批准号:
    10589511
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
MAINTENANCE OF MITOCHONDRIAL PROTEIN FOLDING AS AN AGING EFFECTOR
线粒体蛋白折叠作为衰老效应物的维持
  • 批准号:
    9357484
  • 财政年份:
    2016
  • 资助金额:
    $ 44.65万
  • 项目类别:
MAINTENANCE OF MITOCHONDRIAL PROTEIN FOLDING AS AN AGING EFFECTOR
线粒体蛋白折叠作为衰老效应物的维持
  • 批准号:
    9923550
  • 财政年份:
    2016
  • 资助金额:
    $ 44.65万
  • 项目类别:
Coordinated Repair and Regeneration of Defective Mitochondria
有缺陷的线粒体的协调修复和再生
  • 批准号:
    10083164
  • 财政年份:
    2015
  • 资助金额:
    $ 44.65万
  • 项目类别:
Coordinated Repair and Regeneration of Defective Mitochondria
有缺陷的线粒体的协调修复和再生
  • 批准号:
    8812947
  • 财政年份:
    2015
  • 资助金额:
    $ 44.65万
  • 项目类别:
Coordinated Repair and Regeneration of Defective Mitochondria
有缺陷的线粒体的协调修复和再生
  • 批准号:
    10371983
  • 财政年份:
    2015
  • 资助金额:
    $ 44.65万
  • 项目类别:
Coordinated Repair and Regeneration of Defective Mitochondria
有缺陷的线粒体的协调修复和再生
  • 批准号:
    9412208
  • 财政年份:
    2015
  • 资助金额:
    $ 44.65万
  • 项目类别:
Maintenance of Mitochondrial Protein Folding as an Aging Effector
维持线粒体蛋白折叠作为衰老效应器
  • 批准号:
    8852514
  • 财政年份:
    2011
  • 资助金额:
    $ 44.65万
  • 项目类别:
Maintenance of Mitochondrial Protein Folding as an Aging Effector
维持线粒体蛋白折叠作为衰老效应器
  • 批准号:
    8235175
  • 财政年份:
    2011
  • 资助金额:
    $ 44.65万
  • 项目类别:
Maintenance of Mitochondrial Protein Folding as an Aging Effector
维持线粒体蛋白折叠作为衰老效应器
  • 批准号:
    8332298
  • 财政年份:
    2011
  • 资助金额:
    $ 44.65万
  • 项目类别:

相似海外基金

Epigenetic Age Acceleration Impacts Racial and Neighborhood Disparities in Chronic Low Back Pain
表观遗传年龄加速影响慢性腰痛的种族和社区差异
  • 批准号:
    10431156
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease
镰状细胞病的表观遗传年龄加速和精神神经症状
  • 批准号:
    10594523
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health
生命早期心血管疾病危险因素、表观遗传年龄加速和阿尔茨海默病相关的大脑健康
  • 批准号:
    10706044
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
The pathway from prenatal pregnancy-specific anxiety to offspring ADHD through epigenetic age acceleration DNA methylation and moderators to target intervention: Partner social support
通过表观遗传年龄加速 DNA 甲基化和调节因子从产前妊娠特异性焦虑到后代 ADHD 的途径:伴侣社会支持
  • 批准号:
    475968
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
    Studentship Programs
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease
镰状细胞病的表观遗传年龄加速和精神神经症状
  • 批准号:
    10449461
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
Functional genetic analysis of epigenetic age acceleration and the regulatory landscape of the methylome
表观遗传年龄加速的功能遗传分析和甲基化组的调控景观
  • 批准号:
    10674263
  • 财政年份:
    2022
  • 资助金额:
    $ 44.65万
  • 项目类别:
Perinatal Maternal Anxiety and Offspring ADHD Symptoms: Mediation Through Epigenetic Age Acceleration DNA Methylation
围产期母亲焦虑和后代 ADHD 症状:通过表观遗传年龄加速 DNA 甲基化进行调节
  • 批准号:
    467256
  • 财政年份:
    2021
  • 资助金额:
    $ 44.65万
  • 项目类别:
    Studentship Programs
CAREER: Understanding the Role of Cu-Containing Secondary Phase Particles in Enhancing the Resistance to the Environmental Acceleration to Fatigue in Age-Hardenable Al Alloys
事业:了解含铜第二相颗粒在增强时效硬化铝合金的环境加速疲劳抵抗力方面的作用
  • 批准号:
    1943870
  • 财政年份:
    2020
  • 资助金额:
    $ 44.65万
  • 项目类别:
    Continuing Grant
Breast Cancer Risk Factors and Epigenetic Age Acceleration
乳腺癌危险因素和表观遗传年龄加速
  • 批准号:
    10614228
  • 财政年份:
    2020
  • 资助金额:
    $ 44.65万
  • 项目类别:
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy
时钟在滴答作响:表观遗传年龄加速作为妊娠期子宫功能的生物标志物
  • 批准号:
    10630244
  • 财政年份:
    2020
  • 资助金额:
    $ 44.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了